Shopping Cart
Remove All
Your shopping cart is currently empty
XmAb 5592
😃Good
Catalog No. T80762Cas No. 1221901-33-2
XmAb 5592 is a Fc-engineered and humanized anti-HM1.24 antibody with anti-tumor activity, used in the study of multiple myeloma.
XmAb 5592
XmAb 5592
😃Good
Catalog No. T80762Cas No. 1221901-33-2
XmAb 5592 is a Fc-engineered and humanized anti-HM1.24 antibody with anti-tumor activity, used in the study of multiple myeloma.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $183 | - | In Stock | |
| 5 mg | $496 | - | In Stock | |
| 10 mg | $795 | - | In Stock | |
| 25 mg | $1,180 | - | In Stock | |
| 50 mg | $1,580 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.51% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | XmAb 5592 is a Fc-engineered and humanized anti-HM1.24 antibody with anti-tumor activity, used in the study of multiple myeloma. |
| Targets&IC50 | HM1.24:1.5 nM (Kd) |
| In vitro | XmAb5592 binds to HM1.24 with high binding affinity and Kd value of 1.5 nM. XmAb 5592 enhanced antibody-dependent cytotoxicity (ADCC) and antibody-dependent cytophagocytosis (ADCP) against multiple myeloma (MM) cells at concentrations ranging from 0 to 1000 ng/mL. XmAb5592 significantly enhanced the cleavage of MM cell lines and significantly increased the maximum cleavage efficiency (EC50 range 5-27 ng/mL). [1] |
| In vivo | SCID mice carrying RPMI8226 subcutaneous tumors were treated twice weekly with 0.9, 3.0, or 9.0 mg/kg of XmAb 5592, which inhibited RPMI8226 tumor growth in a dose-dependent manner. Its antitumor activity is mediated by an Fgamra-dependent mechanism. A single intravenous infusion of XmAb5592 at 20 mg/kg showed that a single dose of XmAb5592 depleted plasma cells in cymavores' blood and BM compartms. [1] |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | BST2/CD317 |
| Molecular Weight | 145.80 kDa |
| Cas No. | 1221901-33-2 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy XmAb 5592 | purchase XmAb 5592 | XmAb 5592 cost | order XmAb 5592 | XmAb 5592 in vivo | XmAb 5592 in vitro | XmAb 5592 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.